A recent study in melanoma cells showed that increased expression of PTENP1-AS resulted in the induction of BRAF inhibitor resistant cells and is likely to be due to the recruitment of epigenetic modifiers to the PTEN promoter region, resulting in reduced PTEN expression [151]. The gene discussed is PTENP1; the disease is melanoma.